Cite
HARVARD Citation
Fakhry, C. et al. (2019). Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials. Cancer. 125 (12), pp. 2027-2038. [Online].